Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587469 · ClinicalTrials.gov registry record
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects
A clinical trial, sponsored by Cepheid.
- Completed
- Registry status
- 992
- Enrollment target
NCT01587469 is a clinical trial that has completed, run by Cepheid. The registered enrollment target is 992 participants.
The verdict
NCT01587469 has completed, sponsored by Cepheid.
- COMPLETED
- Registry status
- 992 participants
- Enrollment target
Study Summary
This observational Mycobacterium tuberculosis (MTB) diagnostics evaluation study is a longitudinal study of pulmonary TB suspects who are undergoing sputum evaluation for pulmonary TB. The sensitivity and specificity of the Xpert MTB/RIF (Mycobacterium tuberculosis/rifampin) assay performed on the first sputum collected for Xpert testing will be compared to gold standard conventional culture methods on two sputum specimens, in HIV-infected and HIV-uninfected participants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 992 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-02-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01587469
The ClinicalTrials.gov registry entry for NCT01587469 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 992 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cepheid, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01587469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01587469 about?
NCT01587469 is a clinical study titled "Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects". This observational Mycobacterium tuberculosis (MTB) diagnostics evaluation study is a longitudinal study of pulmonary TB suspects who are undergoing sputum evaluation for pulmonary TB. The sensitivity and specificity of the Xpert MTB/RIF (Mycobacterium tuberculosis/rifampin) assay performed on the f...
What is the current status of trial NCT01587469?
This trial is currently completed. The enrollment target is 992 participants. The study started on 2012-05. Estimated completion is 2014-02-21.
Who is sponsoring clinical trial NCT01587469?
This trial is sponsored by Cepheid, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.